Endothelin-1 plasma levels in hemodialysis treatment - The influence of type 2 diabetes

Renal Failure

Volumn 27, Issue 5, 2005, Pages 515-522

  Liakopoulos, Vasilios ^a   Wurth, Patrick ^b   Mertens, Peter Rene ^b   Eleftheriadis, Theodores ^a   Kourti, Panagiota ^a   Voliotis, Georgios ^a   Heintz, Bernhard ^b   Koukoulis, Georgios N ^a   Stefanidis, Ioannis ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Diabetes mellitus; End stage renal disease; Endothelin 1; Hemodialysis

Indexed keywords

ENDOTHELIN 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD VOLUME; CLINICAL ARTICLE; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOCONCENTRATION; HEMODIALYSIS; HUMAN; MALE; MITOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; ULTRAFILTRATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RENAL DIALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 24044439756     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500198250     Document Type: Article

References (45)

1. Vane, J.R.; Anggard, E.E.; Bolting, R.M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 1990, 323, 27-36.
2. Yanagisawa, M.; Kurihara, H.; Kimura, S.; Yomobe, Y.; Kobayashi, M.; Mitssui, Y.; et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332, 411-415.
3. Wagner, O.F.; Christ, G.; Wojta, J. Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem. 1992, 267, 16066-16068.
4. Mather, K.; Mirzamohammadi, B.; Lteif, A.; Steinberg, H.; Baron, A. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 2002, 51, 3517-3523.
5. Haynes, W.G.; Webb, D.J. Contribution of endogenous generation of endothelin-1 to basal vascular tone in man. Lancet 1994, 244, 852-854.
6. Akizawa, T.; Kinugasa, E.; Koshikawa, S. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis. ASAIO Trans. 1991, 37, M384-M385.
7. Koyama, H.; Tabata, T.; Nishzawa, Y.; Inoue, T.; Morii, H.; Yamaji, T. Plasma endothelin levels in patients with uraemia. Lancet 1989, 1, 991-992.
8. Mallamaci, F.; Parlongo, S.; Zoccali, C. Influence of cardiovascular damage and residual renal function on plasma endothelin in chronic renal failure. Nephron 1993, 63, 291-295.
9. Niwa, T.; Fujishiro, T.; Uema, K.; et al. Effect of hemodialysis on plasma levels of vasoactive peptides: endothelin, calcitonin gene-related peptide and human atrial natriuretic peptide. Nephron 1993, 64, 552-559.
10. Stockenhuber, F.; Gottsauner-Wolf, M.; Marosi, L.; Liebisch, B.; Kurz, R.W.; Balcke, P. Plasma levels of endothelin in chronic renal failure and after renal transplantation: impact on hypertension and cyclosporin A-associated nephrotoxicity. Clin. Sci. Colch. 1992, 82, 255-258.
11. Warrens, A.N.; Cassidy, M.J.; Takahashi, K.; Ghatei, M.A.; Bloom, S.R. Endothelin in renal failure. Nephrol. Dial. Transplant. 1990, 5, 418-422.
12. Stefanidis, I.; Mertens, P.R.; Wurth, P.; Bach, R.; Makropoulos, W.; Mann, H.; et al. Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis. Int. J. Artif. Organs 2001, 24, 367-373.
13. Lebel, M.; Grose, J.H.; Kingma, L; Langlois, S. Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients. Effect of subcutaneous erythropoietin replacement therapy. Clin. Exp. Hypertens. 1994, 16, 565-575.
14. DeVriese, A.; Verbeuren, T.; Van de Voorde, J.; Lameire, N.; Vanhoutte, P. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 2000, 130, 963-974.
15. Takeda, Y.; Miyamori, I.; Yoneda, T.; Takeda, R. Production of endothelin-1 from the mesenteric artery of streptozotocin-induced diabetic rats. Life Sci. 1991, 48, 2553-2556.
16. Makino, A.; Kamata, K. Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of mesenteric arterial bed to endothelin-1. Br. J. Pharmacol. 1998, 123, 1065-1072.
17. Hopfner, R.; McNeill, J.; Gopalakrishnan, V. Endothelin plasma levels and endothelin-1 evoked vascular responses at different temporal stages of diabetes in streptozotocin rats. Eur. J. Pharmacol. 1999, 374, 221-227.
18. Hattori, Y.; Kassai, K.; Nakamura, T.; Emoto, T.; Shimoda, S. Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism 1991, 40, 165-170.
19. Donatelli, M.; Colletti, I.; Bucalo, M.; Russo, V.; Verga, S. Plasma endothelin levels in NIDDM patients with macroangiopathy. Diabetes Res. 1994, 25, 159-164.
20. Morise, T.; Takeuchi, Y.; Kawano, M.; Koni, I.; Takeda, R. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 1997, 18, 87-89.
21. Guvener, N.; Aytemir, K.; Aksoyek, S.; Gedik, O. Plasma endothelin-1 levels in non-insulin dependent diabetes mellitus patients with macrovascular disease. Coron. Artery Dis. 1997, 8, 253-258.
22. Migdalis, I.; Kalogeropoulou, K.; Iliopoulou, V.; Triantafilou, P.; Charalabides, J.; Mortzos, G.; et al. Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy. Diabetes Res. Clin. Pract. 2001, 54, 129-136.
23. Bagg, W.; Ferri, C.; Desideri, G.; Gamble, G.; Ockelford, P.; Braatvedt, G. The influence of obesity and glycemic control on endothelial activation in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 2001, 86, 5491-5497.
24. Piatti, P.; Monti, L.; Galli, L.; Fragasso, G.; Valsecchi, G.; Conti, M.; et al. Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome. Metabolism 2000, 49, 748-752.
25. Wolesen, F.; Berglund, L.; Berne, C. Plasma endothelin-1 and total onsulin exposure in diabetes mellitus. Clin. Sci. Colch. 1999, 97, 149-156.
26. Chakrabarti, S.; Khan, Z.; Cukiernik, M.; Fukuda, G.; Chen, S.; et al. Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications. Int. J. Exp. Diabetes Res. 2002, 3, 217-231.
27. van Beaumont, W. Evaluation of hemoconcentration from hematocrit measurements. J. Appl. Physiol. 1972, 32, 712-713.
28. Mann, H.; Stefanidis, I.; Reinhardt, B.; Stiller, S. Prevention of haemodynamic risks by continuous blood volume measurement and control. Nephrol. Dial. Transplant. 1996, 11 (Suppl. 2), 48-51.
29. Banks, R.O. Effects of endothelin on renal function in dogs and rats. Am. J. Physiol. 1990, 258, F775-F780.
30. Cao, L.Q.; Banks, R.O. Cardiovascular and renal actions of endothelin: effects of calcium-channel blockers. Am. J. Physiol. 1990, 258, F254-F258.
31. Kohno, M.; Murakawa, K.; Yasunari, K.; Yokokawa, K.; Horio, T.; Kurihara, N.; et al. Prolonged blood pressure elevation after endothelin administration in bilaterally nephrectomized rats. Metabolism 1989, 38, 712-713.
32. Lariviere, R.; D'Amours, M.; Lebel, M.; Kingma, I.; Grose, J.H.; Caron, L. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass. Kidney Blood Press. Res. 1997, 20, 372-380.
33. Deray, G.; Carayon, A.; Maistre, G.; Benhmida, M.; Masson, F.; Barthelemy, C.; et al. Endothelin in chronic renal failure. Nephrol. Dial. Transplant. 1992, 7, 300-305.
34. Miyauchi, T.; Suzuki, N.; Kurihara, T.; Yamaguchi, I.; Sugishita, Y.; Matsumoto, H.; et al. Endothelin-1 and endothelin-3 play different roles in acute and chronic alterations of blood pressure in patients with chronic hemodialysis. Biochem. Biophys. Res. Commun. 1991, 178, 276-281.
35. Ross, R.D.; Kalidindi, V.; Vincent, J.A.; Kassab, J.; Dabbagh, S.; Hsu, J.M.; et al. Acute changes in endothelin-1 after hemodialysis for chronic renal failure. J. Pediatr. 1993, 122, S74-S76.
36. Surdacki, A.; Sulowicz, W.; Wieczorek-Surdacka, E.; Herman, Z.S. Effect of a hemodialysis session on plasma levels of endothelin-1 in hypertensive and normotensive subjects with end-stage renal failure. Nephron 1999, 81, 31-36.
37. Kohno, M.; Yasunari, K.; Yokokawa, K.; Murakawa, K.; Horio, T.; Kanayama, Y.; et al. Thrombin stimulates the production of immunoreactive endothelin-1 in cultured human umbilical vein endothelial cells. Metabolism 1990, 39, 1003-1005.
38. Carlini, R.G.; Gupta, A.; Liapis, H.; Rothstein, M. Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells. J. Cardiovasc. Pharmacol. 1995, 26, 889-892.
39. Carlini, R.; Obialo, C.I.; Rothstein, M. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients. Am. J. Hypertens. 1993, 6, 103-107.
40. Yokokawa, K.; Kohno, M.; Tahara, H.; Mandal, A.K.; Yasunari, K.; Murakawa, K.; Horio, T.; Ikeda, M.; Minami, M.; Takeda, T. Effect of heparin on endothelin-1 production by cultured human endothelial cells. J. Cardiovasc. Pharmacol. 1993, 22 (Suppl. 8), S46-S48.
41. Ferri, C.; Pittoni, V.; Piccoli, A.; Laurenti, O.; Cassone, M.; Bellini, C.; et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J. Clin. Endocrinol. Metab. 1995, 80, 829-835.
42. De Mattia, G.; Casone-Faldetta, M.; Bellini, C.; Bravi, M.; Laurenti, O.; Baldonici, R.; et al. Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy. Am. J. Hypertens. 1998, 11, 983-988.
43. Cardillo, C.; Campia, U.; Bryant, M.; Panza, J. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 2002, 106, 1783-1787.
44. Lerman, A.; Edward, B.; Hallet, J.; Heublein, D.; Sandberg, S.; Burnett, JJ. Circulating and tissue immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 1991, 325, 997-1001.
45. Stefanidis, I.; Wurth, P.; Mertens, P.R.; Ikonomov, V.; Philippidis, G.; Golphinopoulos, S.; et al. Plasma endothelin-1 9n hemodialysis treatment - the influence of hypertension. J. Cardiovasc. Pharmacol. 2004, 44, 543-548.